An Evaluation of the Effect of Community-based Pharmacist Intervention on Patients With Chronic Pain
1 other identifier
interventional
19
1 country
1
Brief Summary
This is a prospective, pre post, pilot cohort study to be conducted in patients with chronic pain, which is defined as pain that lasts beyond 3 months. To accomplish the primary and secondary objectives of the study, three phrases will be designed and completed during three months
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable chronic-pain
Started Feb 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2016
CompletedFirst Submitted
Initial submission to the registry
May 10, 2016
CompletedFirst Posted
Study publicly available on registry
March 22, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2017
CompletedNovember 17, 2017
November 1, 2017
1.2 years
May 10, 2016
November 15, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Pain intensity change
Pain intensity will be measured with Brief Pain Inventory pain intensity subscale, and will be measured 3 times in total
baseline, 2 weeks follow-up, 3 months follow-up
Secondary Outcomes (2)
Pain interference
baseline, 2 weeks follow-up, 3 months follow-up
Quality of life change
baseline, 3 months follow-up
Other Outcomes (1)
patient adherence
2 weeks follow-up and 3 months follow-up
Study Arms (1)
Pharmacist intervention
EXPERIMENTALWithin the pharmacist intervention arm, pharmacists will do medication reviews, assessment, recommendations, education.
Interventions
Eligibility Criteria
You may qualify if:
- Aged 18 or older
- Baseline average pain intensity using Brief Pain Inventory is 6 or higher
- Ambulatory and able to attend the intervention
- Complaining of pain for 3 months or longer
You may not qualify if:
- Patients with malignant or cancer pain
- Patients who are unable to communicate in English
- Non-ambulatory and unable to attend the intervention at the participating site
- Unable to give informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The PharmaShoppe
Kitchener, Ontario, N2G4X6, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Feng Chang
University of Waterloo
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 10, 2016
First Posted
March 22, 2017
Study Start
February 1, 2016
Primary Completion
May 1, 2017
Study Completion
May 1, 2017
Last Updated
November 17, 2017
Record last verified: 2017-11
Data Sharing
- IPD Sharing
- Will not share